Evidence map›Paper›PMID 39346844›Full record

ArticleACS omega2024

Transparent, Antibiofouling Window Obtained with Surface Nanostructuring.

Wiktoria K Szapoczka, Viljar H Larsen, Hanna Böpple, Dorinde M M Kleinegris, Zhaolu Diao, Tore Skodvin, Joachim P Spatz, Bodil Holst, Peter J Thomas

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wiktoria K SzapoczkaUniversity of Bergen, Department of Physics and Technology, Bergen 5007, Norway.ORCID https://orcid.org/0000-0002-1115-2523
Viljar H LarsenUniversity of Bergen, Department of Physics and Technology, Bergen 5007, Norway.
Hanna BöppleNORCE Norwegian Research Centre AS, Bergen 5008, Norway.
Dorinde M M KleinegrisUniversity of Bergen, Department of Biological Sciences, Bergen 5006, Norway.
Zhaolu DiaoDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Heidelberg D-69120, Germany.
Tore SkodvinUniversity of Bergen, Department of Chemistry, Bergen 5007, Norway.
Joachim P SpatzDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Heidelberg D-69120, Germany.ORCID https://orcid.org/0000-0003-3419-9807
Bodil HolstUniversity of Bergen, Department of Physics and Technology, Bergen 5007, Norway.
Peter J ThomasNORCE Norwegian Research Centre AS, Bergen 5008, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofouling is one of the key factors which limits the long-term performance of seawater sensors. Common measures to hinder biofouling include toxic paints, mechanical cleaning and UV radiation. All of these measures have various limitations. A very attractive solution would be to prevent biofilm formation by changing the surface structure of the sensor. This idea has been implemented successfully in various settings, but little work has been done on structuring optically transparent materials, which are often needed in sensor applications. In order to achieve good antibiofouling properties and efficient optical transparency, the structuring must be on the nanoscale. Here, we investigate a transparent, antibiofouling surface obtained by patterning a semihexagonal nanohole structure on borosilicate glass. The nanoholes are approximately 50 nm in diameter and 200 nm deep, and the interparticle distance is 135 nm, allowing the structure to be optically transparent. The antibiofouling properties of the surface were tested by exposing the substrates to the microalgae

Identifiers

PMID39346844
PMCPMC11425857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.